Objectives”, explains how to select and use various test methods for evaluating disease
states, the prognosis, and the effects of treatment. References to the literature published …

Myocardial perfusion imaging (MPI) is an established diagnostic test that provides useful
prognostic data in patients with known or suspected coronary artery disease. In more than …

Cardiac risk assessment before kidney transplantation has become widely accepted.
However, the optimal patient selection and screening tool for cardiac assessment remain …

Background Exercise activity reduces mortality and favorably influences mediators of risk,
including myocardial flow reserve (MFR) and chronotropic responsiveness. Comprehensive …

Background The prognostic value of regadenoson SPECT myocardial perfusion imaging
(MPI) has not been specifically studied in patients with end-stage renal disease (ESRD) …

More than 20 million adults have chronic kidney disease (CKD) and nearly one-half million
people have end-stage renal disease (ESRD) in the United States 1 and with increasing …

Abstract Purpose of Review Patients with end-stage renal disease (ESRD) have an
increased risk of cardiovascular morbidity and mortality. Cardiac risk assessment, though …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

Purpose Noninvasive stress testing is commonly performed as part of pre-renal
transplantation (RT) evaluation. We evaluated the prognostic value of myocardial perfusion …

Regadenoson is a selective A 2A adenosine receptor agonist that has been approved as a
vasodilator stress agent with single-photon emission-computed tomography (SPECT) …